Target intelligence / Profile preview

Epidermal keratinocyte cell membrane integrity disruption

Molecular classification
Other
01

Overview

Epidermal keratinocyte cell membrane integrity disruption" refers to pathological loss of the structural barrier formed by keratinocyte plasma membranes in the epidermis. This loss of integrity can be induced by a variety of mechanisms including lytic cell death (such as necroptosis, calcium-influx-dependent lysis via TRPV3, or excessive apoptosis), alterations of membrane lipid domains (especially cholesterol-dependent lipid rafts), and external injuries such as solvent exposure. Disruption leads to impaired barrier function, initiating inflammation, increased permeability to pathogens and environmental irritants, and triggering compensatory keratinocyte proliferation and differentiation. No single molecule or receptor defines this entity; rather, it encompasses a constellation of processes and regulatory pathways central to skin pathology and injury responses [1][2][3][4][5][6].

02

Mechanism of action

TRPV3-mediated calcium influx leading to lytic cell death; Cholesterol depletion disrupting lipid rafts and signaling; Loss of apoptosis inhibition (e.g., via cFLIP, IAP inhibition) causing excessive keratinocyte death

03

Biological functions

Cell membrane integrityCell deathBarrier functionInflammatory signalingKeratinocyte proliferation and differentiation
04

Disease associations

InflammationDermatitisBarrier disordersInfection
05

Safety considerations

Risk of severe skin inflammation (e.g., akin to toxic epidermal necrolysis)Loss of barrier increases risk of infectionInduced cell death may propagate inflammatory responses
06

Interacting drugs

Carvacrol (TRPV3 activator)
07

Biomarkers

Filaggrin expression (for barrier impairment)K10 and transglutaminase activity (for differentiation)Cell membrane-impermeable dye uptake (e.g., Evans blue for acute rupture)

Beyond the preview

Go deeper on Epidermal keratinocyte cell membrane integrity disruption.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epidermal keratinocyte cell membrane integrity disruption.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call